Suchergebnisse - "Beretta, Lorenzo"

PubPharm (7)

1

Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

enthalten in: Journal of autoimmunity | 2023

von Lindblom, J. | Toro-Domínguez, D. | Carnero-Montoro, E. | +9

ErratumIn: J Autoimmun. 2023 May 2;:103052. - PMID 37142531

2

Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year

enthalten in: Clinical immunology (Orlando, Fla.) | 2021

von Ramirez, G. | Argolini, L. | Bellocchi, C. | +9

3

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

enthalten in: Journal of nephrology | 2020

von Binda, V. | Trezzi, B. | Del Papa, N. | +8

4

COVID-19 in systemic lupus erythematosus : Data from a survey on 417 patients

enthalten in: Seminars in arthritis and rheumatism | 2020

von Ramirez, G. | Gerosa, M. | Beretta, L. | +10

5

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

enthalten in: Journal of nephrology | 2020

von Binda, V. | Trezzi, B. | Del Papa, N. | +8

6

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

enthalten in: Journal of nephrology / Supplement | 2020

von Binda, V. | Trezzi, B. | Del Papa, N. | +8

7

Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

enthalten in: Journal of nephrology | 2020

von Binda, V. | Trezzi, B. | Del Papa, N. | +8

1
[1]